BTBP(SH:600161) Xin Lang Cai Jing·2025-09-22 10:16Core Viewpoint - TianTan Bio announced that its subsidiary Chengdu Rongsheng Pharmaceutical Co., Ltd. received a GMP compliance inspection notice from the Sichuan Provincial Drug Administration, indicating that the production facility meets national GMP requirements [1] Group 1: Regulatory Compliance - The certificate number for the GMP compliance inspection is 川许2025169, with the inspection conducted from June 16 to June 19, 2025 [1] - The inspection concluded that the facility complies with the "Drug Production Quality Management Standards (2010 Revision)" and related appendices [1] Group 2: Product Development - The receipt of the notice signifies that Chengdu Rongsheng's production workshop for recombinant products is compliant with national standards [1] - The company is awaiting the registration certificate and final production license for "Recombinant Human Coagulation Factor VIIa for Injection" to commence production [1]